New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents
K Gurova - Future oncology, 2009 - Taylor & Francis
Most of the anticancer chemotherapeutic drugs that are broadly and successfully used today
are DNA-damaging agents. Targeting of DNA has been proven to cause relatively potent …
are DNA-damaging agents. Targeting of DNA has been proven to cause relatively potent …
Calmodulin
CB Klee, TC Vanaman - Advances in protein chemistry, 1982 - Elsevier
Publisher Summary Calmodulin is the major intracellular, and intramembrane, Ca 2+
receptor. Its function is to detect free Ca 2+ and translate changes in Ca 2+ concentrations …
receptor. Its function is to detect free Ca 2+ and translate changes in Ca 2+ concentrations …
Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors
T Tsuruo, H Iida, S Tsukagoshi, Y Sakurai - Cancer research, 1982 - AACR
Some calcium antagonists and calmodulin inhibitors enhance the intracellular levels of
vincristine and Adriamycin in vincristine-and Adriamycin-resistant P388 leukemia cells by …
vincristine and Adriamycin in vincristine-and Adriamycin-resistant P388 leukemia cells by …
[图书][B] Pharmacology and Therapeutics for Dentistry-E-Book: Pharmacology and Therapeutics for Dentistry-E-Book
JA Yagiela, FJ Dowd, B Johnson, A Mariotti, EA Neidle - 2010 - books.google.com
Use your knowledge of pharmacology to enhance oral care! Pharmacology and
Therapeutics for Dentistry, 6th Edition describes how to evaluate a patient's health and …
Therapeutics for Dentistry, 6th Edition describes how to evaluate a patient's health and …
Interaction of drugs with calmodulin: biochemical, pharmacological and clinical implications
B Weiss, WC Prozialeck, TL Wallace - Biochemical pharmacology, 1982 - Elsevier
A tenet of biochemical pharmacology is that the pharmacological effects of drugs are
ultimately explainable by discrete biochemical actions. The caveat, of course, is that a …
ultimately explainable by discrete biochemical actions. The caveat, of course, is that a …
Modulation of morphogenesis in Candida albicans by various small molecules
J Shareck, P Belhumeur - Eukaryotic cell, 2011 - Am Soc Microbiol
The pathogenic yeast Candida albicans, a member of the mucosal microbiota, is
responsible for a large spectrum of infections, ranging from benign thrush and vulvovaginitis …
responsible for a large spectrum of infections, ranging from benign thrush and vulvovaginitis …
The use of quinacrine (Atabrine) in rheumatic diseases: a reexamination
DJ Wallace - Seminars in arthritis and rheumatism, 1989 - Elsevier
Atabrine has been available for nearly 60 years. It has a variety of actions and has been
administered to millions of individuals. Its antirheumatic properties have been well …
administered to millions of individuals. Its antirheumatic properties have been well …
Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies
A Lerner, PM Epstein - Biochemical Journal, 2006 - portlandpress.com
The cAMP signalling pathway has emerged as a key regulator of haematopoietic cell
proliferation, differentiation and apoptosis. In parallel, general understanding of the biology …
proliferation, differentiation and apoptosis. In parallel, general understanding of the biology …
Calmodulin: a potential target for cancer chemotherapeutic agents.
WN Hait, JS Lazo - Journal of Clinical Oncology, 1986 - ascopubs.org
Calmodulin is a ubiquitous, calcium-binding protein that is responsible for many of the
intracellular actions of calcium. Recent evidence suggests that calmodulin may regulate …
intracellular actions of calcium. Recent evidence suggests that calmodulin may regulate …
Inhibition of calcium-induced calcium release from purified cardiac sarcoplasmic reticulum vesicles.
BK Chamberlain, P Volpe, S Fleischer - Journal of Biological Chemistry, 1984 - ASBMB
A variety of reagents (local anesthetics, phenothiazines, ruthenium red, ryanodine,
dicyclohexylcarbodiimide, R 24571) inhibit Ca2+-induced Ca2+ release from purified canine …
dicyclohexylcarbodiimide, R 24571) inhibit Ca2+-induced Ca2+ release from purified canine …